PHIO PHARMACEUTICALS CORP. Depreciation
PHIO PHARMACEUTICALS CORP. (PHIO) reported Depreciation of $2.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-03-31
- PHIO PHARMACEUTICALS CORP. depreciation for fiscal 2024 was $2.00K, a 96.43% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. depreciation for fiscal 2023 was $56.00K, a 21.13% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. depreciation for fiscal 2022 was $71.00K, a 5.33% decline from fiscal 2021.
- PHIO PHARMACEUTICALS CORP. depreciation for fiscal 2021 was $75.00K.
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $2.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $56.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $71.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $75.00K 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |